“Efficacy and Tolerability of Valganciclovir 6 Months Vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial”. European Journal of Clinical Medicine, vol. 3, no. 1, Jan. 2022, pp. 18-25, https://doi.org/10.24018/clinicmed.2022.3.1.122.